M8 Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

M8 Pharmaceuticals Ownership

Who owns M8 Pharmaceuticals?

M8 Pharmaceuticals is owned by Acino International AG. It was acquired on September 20, 2023.

Was M8 Pharmaceuticals formerly PE-backed?

Yes. M8 Pharmaceuticals was formerly owned by 2 private investors.

M8 Pharmaceuticals Business Overview

Where is M8 Pharmaceuticals headquartered?

M8 Pharmaceuticals is headquartered in Brewyn, Pennsylvania.

What sector is M8 Pharmaceuticals in?

M8 Pharmaceuticals is a life science company.

When was M8 Pharmaceuticals founded?

M8 Pharmaceuticals was founded in 2007.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 206 acquisitions of life science companies in 2023, including 27 acquisitions by private equity firms, and 179 by strategics.

M8 Pharmaceuticals

M8 Pharmaceuticals, Inc.

1055 Westlakes Drive, Suite 300,
Brewyn, Pennsylvania 19312
United States,
(610) 727-4018
www.m8pharmaceuticals.com

M8 Pharmaceuticals is a pharmaceutical company focused on licensing, marketing, and distributing therapeutics serving Brazil and Latin American markets. M8 Pharmaceuticals was founded in 2007 and is based in Berwyn, Pennsylvania.


 Subscribe to unlock this and 209,180
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.